Incorporation of a Genetic Factor into an Epidemiologic Model for Prediction of Individual Risk of Lung Cancer: The Liverpool Lung Project

被引:44
|
作者
Raji, Olaide Y. [1 ]
Agbaje, Olorunsola F. [2 ]
Duffy, Stephen W. [3 ]
Cassidy, Adrian [1 ]
Field, John K. [1 ]
机构
[1] Univ Liverpool, Canc Res Ctr, Roy Castle Lung Canc Res Programme, Sch Canc Studies, Liverpool L3 9TA, Merseyside, England
[2] Kings Coll London, Div Canc Studies, Canc Epidemiol Unit, Sch Med,Guys Hosp, London WC2R 2LS, England
[3] Queen Mary Univ London, Canc Res UK Ctr EMS, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London, England
关键词
LOGISTIC-REGRESSION-MODEL; BREAST-CANCER; SEZ6L GENE; FIT TESTS; IDENTIFICATION; BIOMARKERS; GOODNESS; AREA; AGE;
D O I
10.1158/1940-6207.CAPR-09-0141
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Liverpool Lung Project (LLP) has previously developed a risk model for prediction of 5-year absolute risk of lung cancer based on five epidemiologic risk factors. SEZ6L, a Met430IIe polymorphic variant found on 22q12.2 region, has been previously linked with an increased risk of lung cancer in a case-control population. In this article, we quantify the improvement in risk prediction with addition of SEZ6L to the LLP risk model. Data from 388 LLP subjects genotyped for SEZ6L single-nucleotide polymorphism (SNP) were combined with epidemiologic risk factors. Multivariable conditional logistic regression was used to predict 5-year absolute risk of lung cancer with and without this SNP. The improvement in the model associated with the SEZ6L SNP was assessed through pairwise comparison of the area under the receiver operating characteristic curve and the net reclassification improvements (NRI). The extended model showed better calibration compared with the baseline model. There was a statistically significant modest increase in the area under the receiver operating characteristic curve when SEZ6L was added into the baseline model. The NRI also revealed a statistically significant improvement of around 12% for the extended model; this improvement was better for subjects classified into the two intermediate-risk categories by the baseline model (NRI, 27%). Our results suggest that the addition of SEZ6L improved the performance of the LLP risk model, particularly for subjects whose initial absolute risks were unable to discriminate into "low-risk" or "high-risk" group. This work shows an approach to incorporate genetic biomarkers in risk models for predicting an individual's lung cancer risk. Cancer Prev Res; 3(5); 664-9. (C) 2010 AACR.
引用
收藏
页码:664 / 669
页数:6
相关论文
共 50 条
  • [31] Construction and validation of a risk prediction model for postoperative lung infection in elderly patients with lung cancer
    Chen, Xiaojie
    Wu, Lixin
    Lan, Gang
    Li, Xiaofeng
    Wang, Xuejing
    Zhang, Ping
    Huang, Weihu
    MEDICINE, 2024, 103 (44)
  • [32] A lung cancer risk prediction model for nonsmokers: A retrospective analysis of lung nodule cohorts in China
    Liao, Zufang
    Zheng, Rongjiong
    Shao, Guofeng
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (11)
  • [33] Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model
    Marcus, Michael W.
    Raji, Olaide Y.
    Duffy, Stephen W.
    Young, Robert P.
    Hopkins, Raewyn J.
    Field, John K.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (01) : 361 - 370
  • [34] Individual 5-Year Lung Cancer Risk Prediction Model in Korea Using a Nationwide Representative Database
    Yeo, Yohwan
    Shin, Dong Wook
    Han, Kyungdo
    Park, Sang Hyun
    Jeon, Keun-Hye
    Lee, Jungkwon
    Kim, Junghyun
    Shin, Aesun
    CANCERS, 2021, 13 (14)
  • [35] Prediction of lung cancer risk in Chinese population with genetic-environment factor using extreme gradient boosting
    Li, Yutao
    Zou, Zixiu
    Gao, Zhunyi
    Wang, Yi
    Xiao, Man
    Xu, Chang
    Jiang, Gengxi
    Wang, Haijian
    Jin, Li
    Wang, Jiucun
    Wang, Huai Zhou
    Guo, Shicheng
    Wu, Junjie
    CANCER MEDICINE, 2022, 11 (23): : 4469 - 4478
  • [36] Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model
    Choi, Eunji
    Luo, Sophia J.
    Ding, Victoria Y.
    Wu, Julie T.
    Kumar, Ashok V.
    Wampfler, Jason
    Tammemaegi, Martin C.
    Wilkens, Lynne R.
    Aredo, Jacqueline V.
    Backhus, Leah M.
    Neal, Joel W.
    Leung, Ann N.
    Freedman, Neal D.
    Hung, Rayjean J.
    Amos, Christopher I.
    Le Marchand, Loic
    Cheng, Iona
    Wakelee, Heather A.
    Yang, Ping
    Han, Summer S.
    CANCER, 2024, 130 (05) : 770 - 780
  • [37] Retrospective Predictive Performance of a Lung Cancer Screening Risk Prediction Model in a Clinical Lung Cancer Screening Program
    Kitts, Andrea Borondy
    Regis, Shawn
    Mckee, Andrea
    Sands, Jacob
    Mckees, Brady
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S356 - S356
  • [38] Improvement of lung cancer risk prediction adding SNPs to the HUNT Lung Cancer Model: A HUNT Study.
    Roe, Oluf D.
    Nguyen, Olav Toai Duc
    Lakiotaki, Klio
    Tsamardinos, Ioannis
    Lagani, Vincenzo
    Markaki, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Gender is a risk factor for lung cancer
    Gasperino, James
    MEDICAL HYPOTHESES, 2011, 76 (03) : 328 - 331
  • [40] Asbestos, risk factor in lung cancer
    Ferrer, Jaume
    Jesus Cruz, Maria
    MEDICINA CLINICA, 2008, 130 (09): : 334 - 335